Tuesday, January 29, 2013
Expanded Bed Adsorption (EBA) is becoming increasingly more accessible for the applications of pharmaceutical research and production. In his feature on the prospects of EBA, separation science expert Dr. Robert Stevenson details how EBA replaces the “capture” stage of bioprocessing. His review of advances in EBA emphasizes how biotherapeutics manufacturers can document product consistency for FDA regulators more easily, as the process scales linearly by column volume from laboratory runs all the way through production runs.
To view the complete Application Note, please click here.